the use of the general consent in chuv/unil
Post on 03-Jan-2017
219 Views
Preview:
TRANSCRIPT
Plateforme de soutien à la recherche clinique
The Use of the General Consent in CHUV/UNIL
Vincent Mooser MD Charles Joye, PhD Chris>ne Currat PhD
Jeanne-‐Pascale Simon, lic. iur
SCTO mee>ng on General Consent Bern, January 28th, 2014
1. Harmonize existing biobanks and align them with the new Human Research Act (HRA) and its Ordinances
2. Establish a general consent for a prospective, systematic biobank designed to support research in genomic medicine (Lausanne Institutional Biobank), which shall be equally applicable for re-use of biological material, as well as genetic and health-related data
Objectives
1. Working group including • CHUV lawyer : Mme Jeanne-Pascale Simon • Biobank manager : Christine Currat PhD • Medical direction : Mirela Caci MD (also lawyer) • Consulting Lawyer : Me Charles Joye • + various experts
2. Start of work in 2011 à 2012
3. Alignment with the preliminary version of HRA, adjustment with amendments and final version of the HRA and Ordinances
Process
General consent for research Ins/tu/onal rules on crea/on,
management and use of biobanks
Documents delivered
BIL
General consent Dedicated team
Includes for full genome sequencing and future contact (social network)
Blood 9 ml
For DNA and plasma
Tissues LeV-‐over from pathology
Clinical data Minimal ques>onnaire
EMR
Formal approval from the local IRB 10/17/12
Design of the Lausanne Institutional Biobank (BIL)
BIL Website : www.chuv.biobanque.ch
1. Staff 1. Operational direction (recruitment unit and
laboratory) :1.5 FTE 2. Team of recruiters : 7.4 FTE 3. Team of specimen management : 2.6 FTE
2. Partners : IT, Medical, Nursing, Patients 3. Perimeter : inpatients admitted electively or
through emergency, outpatients
Opera>onal Aspects of Implementa>on of GC
Pa/ents recruited : n = 15’214
BIL : Recrutement au 5 février 2013 BIL : Recruitment on December 31st, 2014
07.01.2013 31.12.2014
Nb de
pa>
ents
No semaines
0
2000
4000
6000
8000
10000
12000
14000
16000
BIL : Recrutement au 5 février 2013 BIL : Participation Rate (Patients contacted by Dec 31st, 2014 : 20’317)
BIL : Recrutement au 5 février 2013 BIL : Participation Rate according to Site where Consent was Presented
n =786 n = 3765 n = 4959 n = 5613
%
Swiss Non-‐Swiss <40 40-‐49 50-‐59 60-‐69 70-‐79 >80 Male Female Catholic Protestant Other
Origin Age Gender Religion
0.1
OR (log) 1 10
BIL : Factors Associated with Par>cipa>on
Murielle Bochud and Cindy Roth, ms in prepara>on
Acceptance higher Refusal higher
n = 11’099
BIL : Recrutement au 5 février 2013 BIL : Proportion of Patients who Want to be Informed about Clinically Actionable Findings
n = 11’099
-‐ Approved by ethics commicee on Dec 15th, 2014 -‐ A model which will be used by SwissPednet
Latest development
A new brochure for pediatric popula/on
1. General consent established in CHUV : significant, multidisciplinary effort
2. Implementation : labor- and ressource intensive
3. High participation rate in a systematic hospital-based genomic research project
4. Large proportion of patients want to be informed about clinically actionable findings
5. Documents and expertise available for construction of Swiss Biobanking Platform.
Conclusions
top related